Researchers at the Wellcome Sanger Institute have harnessed the power of machine learning to uncover 370 previously undiscovered drug targets for various types of cancer, including breast cancer, cervical cancer, and glioblastoma. The findings, published in Cancer Cell on January 11th, 2024, represent a significant leap forward in the quest for precision medicine and could
